Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciro Gallo

Showing results (51-60 of 112) with videos related to

Pageof 12
Sort By:
The Lancet. Oncology|September 19, 2014
Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient dataAntonio Rossi, Paolo Chiodini, Jong-Mu Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Prognostic value of CD40 in adult soft tissue sarcomasAlessandro Ottaiano, Anna De Chiara, Francesco Perrone, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2013
Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trialEmanuele Durante-Mangoni, Giuseppe Signoriello, Roberto Andini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reactionGiuseppe Palmieri, Paolo A Ascierto, Francesco Perrone, et al.
Cancer|August 24, 2005
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European studyLuca Cindolo, Jean-Jacques Patard, Paolo Chiodini, et al.
BMJ Open|September 11, 2019
Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocolSilvia Riva, Jane Bryce, Francesco De Lorenzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2012
Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient dataAntonio Rossi, Massimo Di Maio, Paolo Chiodini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2013
Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumabSecondo Lastoria, Maria Carmela Piccirillo, Corradina Caracò, et al.
Clinical Lung Cancer|January 15, 2014
Rationale and design of MILES-3 and MILES-4 studies: two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancerCesare Gridelli, Antonio Rossi, Massimo Di Maio, et al.
Journal of Translational Medicine|February 14, 2013
Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanomaAntonio Daponte, Simona Signoriello, Luigi Maiorino, et al.
Pageof 12

Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
The Lancet. Oncology|September 19, 2014
Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient dataAntonio Rossi, Paolo Chiodini, Jong-Mu Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Prognostic value of CD40 in adult soft tissue sarcomasAlessandro Ottaiano, Anna De Chiara, Francesco Perrone, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2013
Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trialEmanuele Durante-Mangoni, Giuseppe Signoriello, Roberto Andini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reactionGiuseppe Palmieri, Paolo A Ascierto, Francesco Perrone, et al.
Cancer|August 24, 2005
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European studyLuca Cindolo, Jean-Jacques Patard, Paolo Chiodini, et al.
BMJ Open|September 11, 2019
Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocolSilvia Riva, Jane Bryce, Francesco De Lorenzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2012
Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient dataAntonio Rossi, Massimo Di Maio, Paolo Chiodini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2013
Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumabSecondo Lastoria, Maria Carmela Piccirillo, Corradina Caracò, et al.
Clinical Lung Cancer|January 15, 2014
Rationale and design of MILES-3 and MILES-4 studies: two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancerCesare Gridelli, Antonio Rossi, Massimo Di Maio, et al.
Journal of Translational Medicine|February 14, 2013
Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanomaAntonio Daponte, Simona Signoriello, Luigi Maiorino, et al.
Pageof 12